4:51 PM
 | 
Jul 16, 2013
 |  BC Extra  |  Financial News

Verastem planning follow-on

Cancer stem cell company Verastem Inc. (NASDAQ:VSTM) proposed a follow-on late Tuesday underwritten by Jefferies and Leerink. Verastem's

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >